Blood levels of neuron-derived small vesicles containing alpha-synuclein and tau protein clumps — both linked to neurodegenerative disorders — can…
Articles by Margarida Maia, PhD
The formation of toxic alpha-synuclein clumps may be the first and critical driver in developing Parkinson’s disease associated with…
Long-term exposure to air pollutants such as fine particulate matter (PM2.5), nitric dioxide, and black carbon increases the risk of…
Using amantadine — a parkinsonian medication that has also antiviral activity — does not reduce the occurrence of COVID-19 or…
Levels of alpha-synuclein, beta-amyloid, and neurofilament light chain (NfL) in the cerebrospinal fluid (CSF) that surrounds the brain and the…
People with early-stage Parkinson’s disease may be about 70% less likely to catch the common cold than those with…
Krill oil, which comes from a shrimp-like animal, protected dopamine-producing neurons from age-related degeneration and boosted neurologic processes dependent on…
A gene therapy designed to track down and keep overactive brain cells in check was able to lower the number…
Add-on treatment with a low dose of zonisamide, an anti-seizure medication, failed to significantly ease tremor in a pilot…
A request to launch a first Phase 1/2 clinical trial of a stem cell-based therapy in people with Parkinson’s…